Elite in Urea Cycle Disorders (UCD)
Check Dr. Gregory M. Enns' experience treating your condition:
About Dr. Gregory M. Enns

Gregory Enns is a Pediatrics specialist and a Medical Genetics expert in Palo Alto, California. Enns has been practicing medicine for over 33 years and is rated as an Elite expert by MediFind in the treatment of Urea Cycle Disorders (UCD). He is also highly rated in 17 other conditions, according to our data. His top areas of expertise are Urea Cycle Disorders (UCD), Ornithine Transcarbamylase Deficiency, Cholesteryl Ester Storage Disease, and Inborn Amino Acid Metabolism Disorder. He is licensed to treat patients in Hawaii and California. Enns is currently accepting new patients.

His clinical research consists of co-authoring 114 peer reviewed articles and participating in 12 clinical trials in the past 15 years. In particular, he has co-authored 11 articles and participated in 5 clinical trials in the study of Urea Cycle Disorders (UCD).


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Gregory M. Enns it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
730 Welch Rd, Suite 2a, Palo Alto, CA 94304
Background & Education
Graduate Institution
Other, 1990
Medical Genetics
Clinical Genetics in CA
Hospital Affiliations
Stanford Hospital
Lucile Packard Childrens Hospital Stanford
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

A Phase 3 Study of PTC923 in Subjects With Phenylketonuria
A Phase 3 Open-Label Extension Study of PTC923 in Phenylketonuria
Longitudinal Study of Urea Cycle Disorders
Short-Term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia
Metabolic and Immune Responses to TIV in Patients With Mitochondrial Disease
Efficacy and Safety Study of Vatiquinone for the Treatment of Mitochondrial Disease Subjects With Refractory Epilepsy
Emergency Use Protocol for EPI-743 in Acutely Ill Patients With Inherited Mitochondrial Respiratory Chain Disease Within 90 Days of End-of-Life Care
View 8 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors